NCT04118504

Brief Summary

Ischemic heart disease is the most frequent cause of mortality in the surrounding countries. Once a coronary event is over, there is a high risk of readmission, recurrence and, mortality, attributed to a sub-optimal control of cardiovascular risk factors (CVRF), highlighting the need to improve secondary prevention strategies aimed at changing lifestyle and therapeutic adherence. Preventive measures should be initiated during hospitalization as recommended by the clinical guidelines. The objective of this study is to evaluate, through a randomized controlled clinical trial, the effect of an intervention based on a web application of health (e-Health) on lifestyle (diet, physical activity and tobacco consumption) and medication adherence in people with coronary heart disease after percutaneous coronary intervention. The sample will consist of 240 participants, 120 in the intervention group and 120 in the usual care group that will be evaluated at the beginning and nine months after hospital discharge regarding sociodemographic, clinical, CVRF, lifestyle and therapeutic adherence characteristics. The educational intervention, monitoring and self-monitoring will be carried out using a web-based e-Health tool, mobile phone application. The quantitative primary results will be compared between the two groups using ANCOVA adjusting for age and sex. Multivariate analysis will be carried out to examine the association of the intervention with life habits, control of CVRF, as well as with the evolution after discharge in respect of cardiovascular events, emergency and re-entry views.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 8, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

July 30, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

August 8, 2022

Status Verified

July 1, 2022

Enrollment Period

1.2 years

First QC Date

September 30, 2019

Last Update Submit

August 5, 2022

Conditions

Keywords

Coronary diseaseLife styleMobile applicationClinical trial

Outcome Measures

Primary Outcomes (7)

  • Adherence to the Mediterranean diet

    14-item Questionnaire of Mediterranean diet adherence (unit of measure: points. Each item is scored 0 or 1. The total Mediterranean diet score ranges from 0 to 14 points. The higher the score, the higher the degree of adherence to the Mediterranean Diet.

    9 months

  • Frequency of food consumption

    Food-frequency questionnaire with 137 food items (unit of measure: number of times per month, week and day)

    9 months

  • Level of physical activity

    Minnesota Leisure Time Physical Activity Questionnaire (unit of measure: Metabolic equivalents-minutes per day. Minimum: 150 metabolic equivalents-minutes per day; active, those with energy expenditure in physical activity equal or greater than 150 metabolic equivalents-minutes per day). Do higher values represent a better outcome.

    9 months

  • The concentration of carbon monoxide in exhaled air

    Smoking cessation: Value \< 6 parts per million of carbon monoxide in exhaled air. Smoker: Value \> 6 parts per million of carbon monoxide in exhaled air.

    9 months

  • Therapeutic adherence

    A 4 items questionnaire (Total score: 4 points. Good therapeutic adherence= 4 points.Poor therapeutic adherence= 1-3 points)

    9 months

  • Knowledge about cardiovascular disease using a questionnaire

    24-item questionnaire (scale 0-5 each item. Do higher values represent a better outcome)

    9 months

  • Usability and satisfaction with the application: 22 item questionnaire

    22 item questionnaire to assess user acceptability of mobile health interventions. (6-point scale, level of disagreement to agreement with each item concerning the usability of the apps. Do higher values represent a better outcome)

    9 months

Study Arms (2)

Intervention group

EXPERIMENTAL

Lifestyle intervention on through mobile application

Device: Mobile application

Control group

NO INTERVENTION

Usual care

Interventions

Lifestyle intervention on through mobile application

Intervention group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants with coronary heart disease
  • Under the age of 75
  • Have a mobile phone
  • with the ability to receive text messages
  • with internet access

You may not qualify if:

  • Severe heart failure
  • Physical disability
  • Dementia
  • Congenital heart disease
  • Rheumatic etiology disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Puerta del Mar

Cadiz, 11010, Spain

Location

Related Publications (1)

  • Bernal-Jimenez MA, Calle G, Gutierrez Barrios A, Gheorghe LL, Cruz-Cobo C, Trujillo-Garrido N, Rodriguez-Martin A, Tur JA, Vazquez-Garcia R, Santi-Cano MJ. Effectiveness of an Interactive mHealth App (EVITE) in Improving Lifestyle After a Coronary Event: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2024 Apr 22;12:e48756. doi: 10.2196/48756.

MeSH Terms

Conditions

Coronary Disease

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • MJ Santi, MD

    Instituto de investigación e innovación biomédica de Cádiz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2019

First Posted

October 8, 2019

Study Start

July 30, 2020

Primary Completion

September 30, 2021

Study Completion

June 30, 2022

Last Updated

August 8, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations